Thymoquinone, as an anticancer molecule: From basic research to clinical investigation

N/ACitations
Citations of this article
285Readers
Mendeley users who have this article in their library.

Abstract

Thymoquinone is an anticancer phytochemical commonly found in black cumin. In this review, we discuss the potential of thymoquinone as anticancer molecule, its mechanism of action and future usage in clinical applications. Thymoquinone exhibits anticancer activity via numerous mechanisms of action, specifically by showing selective antioxidant and oxidant activity, interfering with DNA structure, affecting carcinogenic signaling molecules/pathways and immunomodulation. In vitro activity of thymoquinone has been further implicated in animal models of cancer; however, no clinical application has been proven yet. This is the optimum time to focus on clinical trials for developing thymoquinone as a future drug in cancer therapeutics.

Cite

CITATION STYLE

APA

Khan, M. A., Tania, M., Fu, S., & Fu, J. (2017, February 7). Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.17206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free